MetaphysicalCells

MetaphysicalCells

Share this post

MetaphysicalCells
MetaphysicalCells
III: TechBio News Day 👾

III: TechBio News Day 👾

🗂️: Research Grid, Quantiphi & DDReg, PicnicHealth, Lantern Pharma, Concr & CariGenetics, Voima Ventures, InnophAI and Vilya

Marina T Alamanou's avatar
Marina T Alamanou
Nov 14, 2024
∙ Paid
3

Share this post

MetaphysicalCells
MetaphysicalCells
III: TechBio News Day 👾
2
Share

Hi everyone, for this week’s update 👉🏼

  • I: TechBio News Day 👾

    🗂️: 10x Genomics, Elsevier, Insilico Medicine, IPA, J Ints Bio, Model Medicines, Antiverse and inCerebro

  • II: TechBio News Day 👾

    🗂️: Oxford Cannabinoid Technologies, DiaGen, Noetik, CellCarta, Lunaphore, Tevogen Bio, Nucleai and Synaffix & BigHat Biosciences

  • III: TechBio News Day 👾

    🗂️: Research Grid, Quantiphi & DDReg, PicnicHealth, Lantern Pharma, Concr & CariGenetics, Voima Ventures, InnophAI and Vilya

“Theory and mythology, natural and supernatural, science and magic are dichotomies shaped by later human reasoning. In fact, all of them are rooted in the search for the underlying forces behind the phenomena and the quest to enlist them on one's side.”


By Azar Gat, War in Human Civilization

III: TechBio News Day 👾

👾 Research Grid Ltd

Research Grid just raised (November 05, 2024) a $6.5M seed round to double down on its mission of making clinical trials faster and more successful (Research Grid raises $6.5 million to make clinical trials admin-free). The round was led by Fuel Ventures, with participation from Arve Capital, Ada Ventures, Morgan Stanley Inclusive Ventures Lab, Arāya Ventures, Ascension Ventures, Plug and Play Ventures, and Atomico Angels, with limited availability remaining.  

Research Grid (UK), an AI startup that helps medical research institutions automate back-office admin for clinical trials, has developed two products, Inclusive and TrialEngine, which together allow its customers to manage the full life cycle of clinical trials in one place. On average, customers of Research Grid see 98% efficiency gains, 45% cost savings and 145% increase in patient engagement.

  • Inclusive is a smart patient, community engagement sourcing and management platform for use in the early trial preparation phase. It has created the largest patient network in the world, providing access to more than 300 million patients across more than 90,000 communities.

  • TrialEngine is a smart clinical trial automation system (CTAS) that handles the administration, data and reporting workflows during the trial and post-trial.

    It leverages custom AI algorithms and process automation to complete tasks such as protocol development, study documents and data extraction in a matter of minutes.

This autumn (Sep 13, 2024) Research Grid was chosen by Morgan Stanley’s in-house accelerator (the Morgan Stanley Inclusive Ventures Lab, MSIVL), which has a proven track record of growing technology and tech-enabled startups around the world, welcomes its 10th cohort.

👾 Quantiphi Analytics Solutions Private Limited & DDReg Pharma Private Limited

On November 5, 2024, Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI (Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI).

Quantiphi is a leading AI-first digital engineering company enabling enterprises to realize transformational opportunities with scalable, secure and adaptable AI solutions. Regarding Healthcare and Life Sciences innovation, they are collaborating with them working as their trusted partners to deliver innovative solutions powered by Cloud, Data, AI and ML. In August 2024, Quantiphi announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator (Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery). This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development.

DDReg is a global regulatory consulting and solutions provider that has supported its customers with compliant drug safety and regulatory solutions for rapid market access. With the intel and experience of over 120 global agencies, subject-matter expertise, and vast industry experience, DDReg stands at the forefront of drug safety and regulatory excellence.

👾 PicnicHealth

PicnicHealth is a leading health technology company dedicated to simplifying healthcare for everyone. With a direct-to-patient approach and a leading AI technology platform, PicnicHealth is making more efficient and comprehensive observational studies a reality.

On September 25, 2024, PicnicHealth announced a clinical service offering that features a virtual clinic designed for patients and a virtual site targeting life sciences organizations (PicnicHealth launches clinical services for patients, life sciences companies). The aim of the two services is to improve care management and stimulate more effective observational research.

The virtual clinic gives patients access to the company's universal patient record system (curated by PicnicHealth's proprietary AI technology, PicnicAI), as well as clinician-guided support designed to help them manage their health more efficiently (100K+ patient journeys mapped). PicnicHealth's virtual site allows life science companies to streamline observational research by looking at a broader range of study designs with fresh data collection methods. 

Co-founder and CEO Noga Leviner co-founded PicnicHealth after she was diagnosed with Crohn’s disease, since she was surprised to find out that there wasn’t a system that would help manage her condition and share all her health data (Observe Ahead of the Curve).

MetaphysicalCells is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Marina T Alamanou
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share